Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction

Fig. 6

Prognostic value of POSTN in patients with BCa Kaplan–Meier analysis were performed in overall survival (A and C) and progression-free survival (B and D) between high POSTN group (> Median, n = 86) and low POSTN group (< Median, n = 87). Survival analysis without (C and D) distant metastases were also taken into consideration. Statistical significance was determined with log-rank test

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us